Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation
- PMID: 7782426
- DOI: 10.1093/oxfordjournals.humrep.a135982
Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation
Abstract
The isolated finding of polycystic-appearing ovaries on ultrasound examination of normal women is not uncommon. The purpose of this study was to determine the clinical significance of polycystic ovaries in a population of healthy, non-hirsute, fertile women preparing to undergo ovarian stimulation. We evaluated whether the finding of polycystic ovaries in oocyte donors predicts a different response to ovarian stimulation when compared to donors with normal-appearing ovaries. Furthermore, we examined whether oocytes from polycystic ovaries had the same capacity for fertilization and development as those retrieved from normal ovaries. In all, 11 donors with polycystic-appearing ovaries were compared prospectively to 13 donors with normal-appearing ovaries who were undergoing ovarian stimulation during the same time interval. The two groups were similar in age and baseline androgen concentrations. Significantly more oocytes were produced by the polycystic group for the amount of human menopausal gonadotrophin (HMG) administered (P < 0.05). In addition, all previous cycles completed by these 24 donors were compared (polycystic group: total of 31 cycles; normal group: total of 37 cycles). The donors with polycystic ovaries required less HMG to obtain optimal stimulation (P < 0.05), attained a greater peak oestradiol concentration (P < 0.05), produced a greater number of follicles (P < 0.05) and oocytes (P < 0.01) and a higher percentage of mature oocytes (P < 0.05). Furthermore, they achieved a higher peak oestradiol/HMG (P < 0.01) and oocytes/HMG ratio (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.Hum Reprod. 1995 Mar;10(3):513-9. doi: 10.1093/oxfordjournals.humrep.a135980. Hum Reprod. 1995. PMID: 7782424
-
Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response.Hum Reprod. 1997 Feb;12(2):294-7. doi: 10.1093/humrep/12.2.294. Hum Reprod. 1997. PMID: 9070714
-
One ovary or two: differences in ovulation induction, estradiol levels, and follicular development in a program for in vitro fertilization.Fertil Steril. 1984 Apr;41(4):524-9. doi: 10.1016/s0015-0282(16)47772-1. Fertil Steril. 1984. PMID: 6423412
-
A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation.Hum Reprod. 1996 May;11(5):1035-7. doi: 10.1093/oxfordjournals.humrep.a019292. Hum Reprod. 1996. PMID: 8671386 Clinical Trial.
-
Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.Hum Reprod. 1996 Nov;11(11):2400-4. doi: 10.1093/oxfordjournals.humrep.a019123. Hum Reprod. 1996. PMID: 8981119 Clinical Trial.
Cited by
-
Pregnancy outcome and follow-up of offspring of donor oocytes recipient from PCOS patients.BMC Pregnancy Childbirth. 2022 Oct 19;22(1):779. doi: 10.1186/s12884-022-05114-y. BMC Pregnancy Childbirth. 2022. PMID: 36261799 Free PMC article.
-
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.Nat Rev Endocrinol. 2011 Apr;7(4):219-31. doi: 10.1038/nrendo.2010.217. Epub 2011 Jan 25. Nat Rev Endocrinol. 2011. PMID: 21263450 Review.
-
The clinical ramifications of polycystic ovarian morphology in oocyte donors.J Assist Reprod Genet. 2013 Feb;30(2):233-8. doi: 10.1007/s10815-012-9924-6. Epub 2013 Jan 5. J Assist Reprod Genet. 2013. PMID: 23292354 Free PMC article.
-
Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women.J Assist Reprod Genet. 1997 May;14(5):254-61. doi: 10.1007/BF02765826. J Assist Reprod Genet. 1997. PMID: 9147238 Free PMC article.
-
Are Patients with Polycystic Ovarian Syndrome Ideal Candidates for Oocyte Donation?Biomed Res Int. 2016;2016:5701609. doi: 10.1155/2016/5701609. Epub 2016 Apr 12. Biomed Res Int. 2016. PMID: 27190994 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources